Litigation Details for Sun Pharmaceutical Industries, Inc. v. Perrigo Company (W.D. Mich. 2018)
✉ Email this page to a colleague
Sun Pharmaceutical Industries, Inc. v. Perrigo Company (W.D. Mich. 2018)
| Docket | 1:18-cv-00530 | Date Filed | 2018-05-10 |
| Court | District Court, W.D. Michigan | Date Terminated | 2018-08-24 |
| Cause | 35:271 Patent Infringement | Assigned To | Janet T. Neff |
| Jury Demand | None | Referred To | Ellen S. Carmody |
| Patents | 8,962,028 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Sun Pharmaceutical Industries, Inc. v. Perrigo Company
The small molecule drug covered by the patent cited in this case is ⤷ Start Trial .
Details for Sun Pharmaceutical Industries, Inc. v. Perrigo Company (W.D. Mich. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-05-10 | External link to document | |||
| 2018-05-10 | 1 | infringement of United States Patent No. 8,962,028 (the “’028 Patent”) (attached as Exhibit A), and …must include, among other things, the patent number of any patent that claims the drug or a method of … Plaintiffs’ Patent Covering Ultravate® 28. The United States Patent & Trademark Office…expiration of the ’028 Patent will constitute an act of infringement of the ’028 Patent. 32. On…became aware of the ’028 Patent no later than the date on which that patent was listed in the Orange | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
